Pan-Cancer Analysis Reveals Ribonuclease K (RNASEK) as a Potential Prognostic Biomarker in Pancreatic Cancer and a Diagnostic Indicator Across Multiple Human Cancers.

Background: Cancer is marked by rapid abnormal cell growth, leading to high mortality. The human Ribonuclease K (RNASEK) gene is involved in various cellular processes, such as viral infection, immune response, and maintaining cellular homeostasis. RNASEK, found in metazoans, contributes to tumor development, but the lack of systemic pan-cancer investigation into the diagnostic and prognostic function of RNASEK, epigenetic regulation, and interaction with the immune cell infiltration remains unclear.